Gilead Licenses Three Masked T Cell Engager Programs
Vir Biotechnology and Gilead entered a collaboration covering three PRO-XTEN dual-masked T-cell engager programs for undisclosed solid-tumor antigens. Vir will discover and optimize candidates; Gilead receives exclusive licenses and will lead downstream development, manufacturing,…
